The C15orf61 Knockout HEK293T Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population designed to disrupt the C15orf61 gene in human HEK293T cells. This product provides a loss-of-function model for investigating the biological role of the uncharacterized protein encoded by C15orf61. The polyclonal knockout format generates a heterogeneous mixture of edited cells, enabling robust functional studies without the need for single?cell clone isolation. By abrogating C15orf61 expression, researchers can explore its potential involvement in cellular processes, leveraging the genetic tractability of the HEK293T host.
HEK293T cells, an adherent human embryonic kidney cell line, are widely utilized in biomedical research due to their high transfectability and capacity for high?level protein expression. These cells constitutively express the SV40 large T antigen, which enables episomal replication of plasmids containing the SV40 origin of replication, thereby enhancing transient transfection efficiency and viral production. As a host for the knockout model, HEK293T cells offer a well?characterized background for studying gene function in a human cellular context, particularly in membrane trafficking and secretory pathway analysis, given their active endomembrane system.
C15orf61 is a poorly characterized gene whose protein product shares homology with the SEC22A SNARE protein, a component of the vesicle fusion machinery. This similarity suggests a potential role in membrane trafficking, possibly mediating vesicle fusion between the endoplasmic reticulum and Golgi. However, upstream regulators, downstream effectors, and interacting partners are unknown, and no signaling pathways have been established. Altered C15orf61 expression has been noted in some cancers, yet its functional significance remains unclear.
The introduction of a C15orf61 disruption in the HEK293T background creates a valuable experimental system for dissecting its potential functions. HEK293T cells are particularly suited for probing membrane trafficking due to their robust secretory pathway and compatibility with advanced imaging techniques. This knockout model permits the design of controlled comparative studies between wild?type and knockout populations, facilitating the identification of phenotypic differences that may shed light on C15orf61’s role. Given the gene??s tentative association with SNARE?mediated processes, researchers can deploy this tool to examine effects on protein secretion, organelle morphology, or vesicle transport kinetics, areas where HEK293T cells provide a reliable and scalable platform.
Typical research applications include functional genomics screens, gene knockout validation, and detailed investigation of C15orf61 biology. The polyclonal knockout cells are suitable for a range of downstream assays, such as western blotting and RT?qPCR to confirm gene disruption, immunofluorescence microscopy to assess protein localization, and phenotypic analyses including proliferation and migration assays. In cancer research contexts, where C15orf61 expression has been found altered, this model can be used to study its impact on tumorigenic properties. For further technical details, product access, or custom services, please contact Ascent Research.
